Loading institutional data...
Loading institutional data...
Held by 235 of 5,944 reporting institutions (93th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 24%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $29.15 today, the market must believe free cash flow compounds 27.2%/yr for a decade (off $15M normalized FCF).
The market's 27.2% is more optimistic than its 7-yr track record.
2-stage DCF · 0.05B shares · net debt -$141M
mean 623.7% · volatility σ 1236% · implied rate exceeded in 1/3 yrs
Central path = implied 27.2%/yr growth; shaded band = ±1σ (1236%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
5/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $18M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 651 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $28.75T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $364.2B | 41.6× | 29.1× | 5.4× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $328.2B | 38.4× | — | 7.2× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $264.2B | 39.7× | 18.8× | 3.0× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| BA | $204.4B | 81.4× | 41.0× | 2.3× | 34.5% | 4.8% | 2.5% | 41.0% | 3.3% | 10.0× | 2,435 |
| DE | $181.0B | 36.2× | — | 4.0× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| ABBNY | $174.3B | 47.1× | 31.1× | 5.4× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $166.7B | 23.4× | 16.0× | 6.8× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $154.3B | 38.1× | — | 5.6× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| HON | $131.9B | 28.2× | 16.2× | 3.5× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| LMT | $123.0B | 25.0× | 16.1× | 1.6× | 5.6% | 10.2% | 6.7% | 74.6% | 17.7% | 2.5× | 2,807 |
| PH | $117.9B | 33.9× | 26.6× | 5.9× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| ADP | $108.7B | 25.0× | — | 5.0× | 6.7% | 46.4% | 20.1% | 73.2% | 40.1% | — | 2,179 |
| GD | $97.3B | 23.3× | 17.1× | 1.9× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| TT | $94.0B | 32.5× | 23.2× | 4.4× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| PWR | $92.6B | 91.1× | 46.0× | 3.3× | 20.3% | 15.0% | 3.6% | 11.5% | 10.6% | 0.4× | 1,659 |
| VRT | $91.6B | 70.2× | 43.4× | 8.9× | 27.7% | 36.3% | 13.0% | 33.8% | 19.4% | 1.4× | 1,748 |
| JCI | $91.6B | 27.9× | — | 3.9× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| HWM | $91.5B | 61.4× | 40.3× | 11.1× | 11.1% | — | 18.3% | 28.2% | 17.9% | 1.3× | 1,399 |
| CSX | $89.1B | 31.1× | 14.4× | 6.3× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| MMM | $86.2B | 27.1× | 16.6× | 3.5× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| WM | $86.2B | 31.9× | 12.1× | 3.4× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| UPS | $83.9B | 15.1× | 9.4× | 0.9× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| EMR | $82.1B | 36.1× | — | 4.6× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| CTAS | $80.4B | 45.3× | 28.9× | 7.8× | 7.7% | 50.0% | 17.5% | 38.7% | 25.5% | 0.8× | 1,366 |
| AMSC | $1.3B | 9.1× | 74.7× | 4.4× | 34.3% | 30.5% | 44.7% | 24.1% | 24.1% | — | 235 |
Peers = companies sharing AMSC's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2026
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $299.2M 100.0% | $222.8M 100.0% | $145.6M 100.0% | $106.0M 100.0% | $108.4M 100.0% | $87.1M 100.0% | $63.8M 100.0% | $56.2M 100.0% | $48.4M 100.0% | $900K 100.0% |
| Cost of Revenue | $207.8M 69.5% | $161.0M 72.2% | $110.4M 75.8% | $97.5M 92.0% | $94.9M 87.6% | — | $54.4M 85.2% | $42.2M 75.1% | $44.6M 92.2% | $64.4M 7150.2% |
| Gross Profit | $91.4M 30.5% | $61.9M 27.8% | $35.3M 24.2% | $8.5M 8.0% | $13.5M 12.4% | — | $9.4M 14.8% | $14.0M 24.9% | $3.8M 7.8% | $10.8M 1204.8% |
| Research & Development | $15.7M 5.3% | $11.4M 5.1% | $8.0M 5.5% | $9.0M 8.5% | $10.5M 9.7% | — | $9.6M 15.0% | $9.9M 17.6% | $11.6M 24.0% | $12.5M 1393.3% |
| Selling, General & Admin | $57.6M 19.3% | $43.1M 19.3% | $31.6M 21.7% | $28.7M 27.1% | $27.5M 25.4% | — | $22.7M 35.5% | $22.0M 39.2% | $22.6M 46.6% | $25.7M 2854.2% |
| Total Operating Expenses | $79.9M 26.7% | $62.9M 28.2% | $46.7M 32.0% | $41.5M 39.2% | $34.6M 31.9% | — | $32.6M 51.0% | -$20.0M -35.6% | $36.0M 74.3% | $38.4M 4265.0% |
| Operating Income | $11.4M 3.8% | -$1.1M -0.5% | -$11.4M -7.8% | -$33.0M -31.1% | -$21.1M -19.4% | -$23.2M -26.6% | -$23.1M -36.2% | $34.0M 60.5% | -$32.2M -66.4% | -$27.5M -3060.2% |
| Other Income (Expense), net | -$1.1M -0.4% | -$265K -0.1% | -$736K -0.5% | -$148K -0.1% | -$28K -0.0% | — | $253K 0.4% | $1.6M 2.8% | -$2.8M -5.8% | $65K 7.2% |
| Pretax Income | $16.7M 5.6% | $2.4M 1.1% | -$10.8M -7.4% | -$34.8M -32.9% | -$21.0M -19.4% | -$23.5M -27.0% | -$16.9M -26.5% | $33.1M 59.0% | -$32.9M -68.0% | -$26.2M -2914.6% |
| Income Tax Expense | -$117.1M -39.1% | -$3.7M -1.6% | $309K 0.2% | $215K 0.2% | -$1.8M -1.7% | -$832K -1.0% | $195K 0.3% | $6.4M 11.4% | -$161K -0.3% | $1.1M 126.9% |
| Net Income | $133.8M 44.7% | -$133.81B -60053.0% | $6.03B 4142.4% | -$11.11B -10483.7% | -$35.04B -32315.2% | -$19.19B -22029.3% | -$17.1M -26.8% | $26.8M 47.6% | -$32.8M -67.7% | -$27.4M -3041.4% |
| Per Share | ||||||||||
| EPS (Basic) | $3.12 | $0.16 | $-0.37 | $-1.26 | $-0.71 | $-0.95 | $-0.81 | $1.32 | $-1.73 | $-1.98 |
| EPS (Diluted) | $3.05 | $0.16 | $-0.37 | $-1.26 | $-0.71 | $-0.95 | $-1.03 | $1.29 | $-1.73 | $-1.98 |
| Weighted Avg Shares (Basic) | 42.9M | 37.0M | 29.8M | 27.8M | 27.2M | 24K | 21.0M | 20.3M | 19.0M | 13.8M |
| Weighted Avg Shares (Diluted) | 43.9M | 37.7M | 29.8M | 27.8M | 27.2M | 24K | 21.1M | 20.7M | 19.0M | 13.8M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-09-17
No material risks flagged.
Where each multiple sits in its own 15-yr range · 33th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 15-yr history.
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 75.1 | 85.2 | — | 87.6 | 92.0 | 75.8 | 72.2 | 69.5 |
| Gross Profit | 24.9 | 14.8 | — | 12.4 | 8.0 | 24.2 | 27.8 | 30.5 |
| R&D | 17.6 | 15.0 | — | 9.7 | 8.5 | 5.5 | 5.1 | 5.3 |
| SG&A | 39.2 | 35.5 | — | 25.4 | 27.1 | 21.7 | 19.3 | 19.3 |
| Operating Income | 60.5 | -36.2 | -26.6 | -19.4 | -31.1 | -7.8 | -0.5 | 3.8 |
| Income Tax | 11.4 | 0.3 | -1.0 | -1.7 | 0.2 | 0.2 | -1.6 | -39.1 |
| Net Income | 47.6 | -26.8 | -22029.3 | -32315.2 | -10483.7 | 4142.4 | -60053.0 | 44.7 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on AMSC: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.